MHC class I immune evasion in MCMV infection

Medical Microbiology and Immunology

Volumn 197, Issue 2, 2008, Pages 191-204

  Doom, Carmen M ^a   Hill, Ann B ^a  

^a OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

Author keywords

CD8 T cell control; Immune evasion; MCMV; MHC class I; Natural infection

Indexed keywords

MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; VIRUS DNA;

ANTIBODY RESPONSE; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELL TYPE; CELLULAR IMMUNITY; COMPARATIVE STUDY; CYTOMEGALOVIRUS; CYTOMEGALOVIRUS INFECTION; EXPERIMENTAL INFECTION; GENE FUNCTION; IMMUNE RESPONSE; IMMUNOCOMPETENCE; INTRAUTERINE INFECTION; MURINE CYTOMEGALOVIRUS; MUTANT; NATURAL KILLER CELL; NONHUMAN; PATHOGENESIS; PHENOTYPE; PRIORITY JOURNAL; REVIEW; T LYMPHOCYTE; VIRAL GENETICS; VIRUS LATENCY; VIRUS REACTIVATION; VIRUS REPLICATION; VIRUS TRANSMISSION;

ANIMALS; CD4-POSITIVE T-LYMPHOCYTES; CD8-POSITIVE T-LYMPHOCYTES; CYTOMEGALOVIRUS INFECTIONS; HISTOCOMPATIBILITY ANTIGENS CLASS I; MICE; MUROMEGALOVIRUS;

EID: 42249108681     PISSN: 03008584     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00430-008-0089-y     Document Type: Review

References (79)

1. Smith MG (1954) Propagation of salivary gland virus of the mouse in tissue cultures. Proc Soc Exp Biol Med 86:435-440
2. Singleton GR, Smith AL, Shellam GR, Fitzgerald N, Muller WJ (1993) Prevalence of viral antibodies and helminths in field populations of house mice (Mus domesticus) in southeastern Australia. Epidemiol Infect 110:399-417
3. Singleton GR, Smith AL, Krebs CJ (2000) The prevalence of viral antibodies during a large population fluctuation of house mice in Australia. Epidemiol Infect 125:719-727
4. Moro D, Lloyd ML, Smith AL, Shellam GR, Lawson MA (1999) Murine viruses in an island population of introduced house mice and endemic short-tailed mice in Western Australia. J Wildl Dis 35:301-310
5. Gorman S, Harvey NL, Moro D, Lloyd ML, Voigt V, Smith LM, Lawson MA, Shellam GR (2006) Mixed infection with multiple strains of murine cytomegalovirus occurs following simultaneous or sequential infection of immunocompetent mice. J Gen Virol 87:1123-1132
6. Booth TW, Scalzo AA, Carrello C, Lyons PA, Farrell HE, Singleton GR, Shellam GR (1993) Molecular and biological characterization of new strains of murine cytomegalovirus isolated from wild mice. Arch Virol 132:209-220
7. Farroway LN, Gorman S, Lawson MA, Harvey NL, Jones DA, Shellam GR, Singleton GR (2005) Transmission of two Australian strains of murine cytomegalovirus (MCMV) in enclosure populations of house mice (Mus domesticus). Epidemiol Infect 133:701-710
8. Pollock JL, Virgin HWt (1995) Latency, without persistence, of murine cytomegalovirus in the spleen and kidney. J Virol 69:1762-1768
9. Kurz S, Steffens HP, Mayer A, Harris JR, Reddehase MJ (1997) Latency versus persistence or intermittent recurrences: evidence for a latent state of murine cytomegalovirus in the lungs. J Virol 71:2980-2987
10. Koffron AJ, Hummel M, Patterson BK, Yan S, Kaufman DB, Fryer JP, Stuart FP, Abecassis MI (1998) Cellular localization of latent murine cytomegalovirus. J Virol 72:95-103
11. Mercer JA, Spector DH (1986) Pathogenesis of acute murine cytomegalovirus infection in resistant and susceptible strains of mice. J Virol 57:497-504
12. Henson D, Strano AJ (1972) Mouse cytomegalovirus. Necrosis of infected and morphologically normal submaxillary gland acinar cells during termination of chronic infection. Am J Pathol 68:183-202
13. Reddehase MJ, Balthesen M, Rapp M, Jonjic S, Pavic I, Koszinowski UH (1994) The conditions of primary infection define the load of latent viral genome in organs and the risk of recurrent cytomegalovirus disease. J Exp Med 179:185-193
14. Reddehase MJ, Weiland F, Munch K, Jonjic S, Luske A, Koszinowski UH (1985) Interstitial murine cytomegalovirus pneumonia after irradiation: characterization of cells that limit viral replication during established infection of the lungs. J Virol 55:264-273
15. Koffron AJ, Mueller KH, Kaufman DB, Stuart FP, Patterson B, Abecassis MI (1995) Direct evidence using in situ polymerase chain reaction that the endothelial cell and T-lymphocyte harbor latent murine cytomegalovirus. Scand J Infect Dis Suppl 99:61-62
16. Pollock JL, Presti RM, Paetzold S, Virgin HWt (1997) Latent murine cytomegalovirus infection in macrophages. Virology 227:168-179
17. Jonjic S, Pavic I, Polic B, Crnkovic I, Lucin P, Koszinowski UH (1994) Antibodies are not essential for the resolution of primary cytomegalovirus infection but limit dissemination of recurrent virus. J Exp Med 179:1713-1717
18. Gold MC, Munks MW, Wagner M, McMahon CW, Kelly A, Kavanagh DG, Slifka MK, Koszinowski UH, Raulet DH, Hill AB (2004) Murine cytomegalovirus interference with antigen presentation has little effect on the size or the effector memory phenotype of the CD8 T cell response. J Immunol 172:6944-6953
19. Arase H, Mocarski ES, Campbell AE, Hill AB, Lanier LL (2002) Direct recognition of cytomegalovirus by activating and inhibitory NK cell receptors. Science 296:1323-1326
20. Smith HR, Heusel JW, Mehta IK, Kim S, Dorner BG, Naidenko OV, Iizuka K, Furukawa H, Beckman DL, Pingel JT et al (2002) Recognition of a virus-encoded ligand by a natural killer cell activation receptor. Proc Natl Acad Sci USA 99:8826-8831
21. Shellam GR, Flexman JP (1986) Genetically determined resistance to murine cytomegalovirus and herpes simplex virus in newborn mice. J Virol 58:152-156
22. Quinnan GVJ, Manischewitz JF (1987) Genetically determined resistance to lethal murine cytomegalovirus infection is mediated by interferon-dependent and -independent restriction of virus replication. J Virol 61:1875-1881
23. Allan JE, Shellam GR (1984) Genetic control of murine cytomegalovirus infection: virus titres in resistant and susceptible strains of mice. Arch Virol 81:139-150
24. Scalzo AA, Fitzgerald NA, Wallace CR, Gibbons AE, Smart YC, Burton RC, Shellam GR (1992) The effect of the Cmv-1 resistance gene, which is linked to the natural killer cell gene complex, is mediated by natural killer cells. J Immunol 149:581-589
25. Katzenstein DA, Yu GS, Jordan MC (1983) Lethal infection with murine cytomegalovirus after early viral replication in the spleen. J Infect Dis 148:406-411
26. Krmpotic A, Busch DH, Bubic I, Gebhardt F, Hengel H, Hasan M, Scalzo AA, Koszinowski UH, Jonjic S (2002) MCMV glycoprotein gp40 confers virus resistance to CD8+ T cells and NK cells in vivo. Nat Immunol 3:529-535
27. Iizuka K, Nakajima C, Iizuka YM, Takase M, Kato T, Noda S, Tanaka K, Kanagawa O (2007) Protection from lethal infection by adoptive transfer of CD8 T cells genetically engineered to express virus-specific innate immune receptor. J Immunol 179:1122-1128
28. Scalzo AA, Lyons PA, Fitzgerald NA, Forbes CA, Shellam GR (1995) The BALB.B6-Cmv1r mouse: a strain congenic for Cmv1 and the NK gene complex. Immunogenetics 41:148-151
29. Lathbury LJ, Allan JE, Shellam GR, Scalzo AA (1996) Effect of host genotype in determining the relative roles of natural killer cells and T cells in mediating protection against murine cytomegalovirus infection. J Gen Virol 77:2605-2613
30. Bukowski JF, Woda BA, Welsh RM (1984) Pathogenesis of murine cytomegalovirus infection in natural killer cell-depleted mice. J Virol 52:119-128
31. Shanley JD (1990) In vivo administration of monoclonal antibody to the NK 1.1 antigen of natural killer cells: effect on acute murine cytomegalovirus infection. J Med Virol 30:58-60
32. Welsh RM, Brubaker JO, Vargas-Cortes M, O'Donnell CL (1991) Natural killer (NK) cell response to virus infections in mice with severe combined immunodeficiency. The stimulation of NK cells and the NK cell-dependent control of virus infections occur independently of T and B cell function. J Exp Med 173:1053-1063
33. Lawson CM, Grundy JE, Shellam GR (1988) Antibody responses to murine cytomegalovirus in genetically resistant and susceptible strains of mice. J Gen Virol 69:1987-1998
34. Tolpin MD, Starr SE, Arbeter AM, Plotkin SA (1980) Inactivated mouse cytomegalovirus vaccine: preparation, immunogenicity, and protective effect. J Infect Dis 142:569-574
35. Farrell HE, Shellam GR (1991) Protection against murine cytomegalovirus infection by passive transfer of neutralizing and non-neutralizing monoclonal antibodies. J Gen Virol 72:149-156
36. Rapp M, Messerle M, Buhler B, Tannheimer M, Keil GM, Koszinowski UH (1992) Identification of the murine cytomegalovirus glycoprotein B gene and its expression by recombinant vaccinia virus. J Virol 66:4399-4406
37. Xu J, Lyons PA, Carter MD, Booth TW, Davis-Poynter NJ, Shellam GR, Scalzo AA (1996) Assessment of antigenicity and genetic variation of glycoprotein B of murine cytomegalovirus. J Gen Virol 77:49-59
38. Geoffroy F, Moachon N, Rodwell J, Quash GA (1996) Murine cytomegalovirus inactivated by sodium periodate is innocuous and immunogenic in mice and protects them against death and infection. Vaccine 14:1686-1694
39. Polic B, Hengel H, Krmpotic A, Trgovcich J, Pavic I, Luccaronin P, Jonjic S, Koszinowski UH (1998) Hierarchical and redundant lymphocyte subset control precludes cytomegalovirus replication during latent infection. J Exp Med 188:1047-1054
40. Jonjic S, Mutter W, Weiland F, Reddehase MJ, Koszinowski UH (1989) Site-restricted persistent cytomegalovirus infection after selective long-term depletion of CD4+ T lymphocytes. J Exp Med 169:1199-1212
41. Jonjic S, Pavic I, Lucin P, Rukavina D, Koszinowski UH (1990) Efficacious control of cytomegalovirus infection after long-term depletion of CD8+ T lymphocytes. J Virol 64:5457-5464
42. Koszinowski UH (1991) Molecular aspects of immune recognition of cytomegalovirus. Transplant Proc 23:70-73, discussion 74
43. Reddehase MJ, Jonjic S, Weiland F, Mutter W, Koszinowski UH (1988) Adoptive immunotherapy of murine cytomegalovirus adrenalitis in the immunocompromised host: CD4-helper-independent antiviral function of CD8-positive memory T lymphocytes derived from latently infected donors. J Virol 62:1061-1065
44. Alterio de Goss M, Holtappels R, Steffens HP, Podlech J, Angele P, Dreher L, Thomas D, Reddehase MJ (1998) Control of cytomegalovirus in bone marrow transplantation chimeras lacking the prevailing antigen-presenting molecule in recipient tissues rests primarily on recipient-derived CD8 T cells. J Virol 72:7733-7744
45. Reddehase MJ, Mutter W, Munch K, Buhring HJ, Koszinowski UH (1987) CD8-positive T lymphocytes specific for murine cytomegalovirus immediate-early antigens mediate protective immunity. J Virol 61:3102-3108
46. Koszinowski UH, Reddehase MJ, Keil GM, Volkmer H, Jonjic S, Messerle M, del Val M, Mutter W, Munch K, Buhler B (1987) Molecular analysis of herpesviral gene products recognized by protective cytolytic T lymphocytes. Immunol Lett 16:185-192
47. Holtappels R, Podlech J, Pahl-Seibert MF, Julch M, Thomas D, Simon CO, Wagner M, Reddehase MJ (2004) Cytomegalovirus misleads its host by priming of CD8 T cells specific for an epitope not presented in infected tissues. J Exp Med 199:131-136
48. Fitzgerald NA, Papadimitriou JM, Shellam GR (1990) Cytomegalovirus- induced pneumonitis and myocarditis in newborn mice. A model for perinatal human cytomegalovirus infection. Arch Virol 115:75-88
49. Fitzgerald NA, Shellam GR (1991) Host genetic influences on fetal susceptibility to murine cytomegalovirus after maternal or fetal infection. J Infect Dis 163:276-281
50. Grundy JE, Mackenzie JS, Stanley NF (1981) Influence of H-2 and non-H-2 genes on resistance to murine cytomegalovirus infection. Infect Immun 32:277-286
51. Shellam GR, Flexman JP, Farrell HE, Papadimitriou JM (1985) The genetic background modulates the effect of the beige gene on susceptibility to cytomegalovirus infection in mice. Scand J Immunol 22:147-155
52. Bukowski JF, Warner JF, Dennert G, Welsh RM (1985) Adoptive transfer studies demonstrating the antiviral effect of natural killer cells in vivo. J Exp Med 161:40-52
53. Krmpotic A, Messerle M, Crnkovic-Mertens I, Polic B, Jonjic S, Koszinowski UH (1999) The immunoevasive function encoded by the mouse cytomegalovirus gene m152 protects the virus against T cell control in vivo. J Exp Med 190:1285-1296
54. Reusch U, Muranyi W, Lucin P, Burgert HG, Hengel H, Koszinowski UH (1999) A cytomegalovirus glycoprotein re-routes MHC class I complexes to lysosomes for degradation. EMBO J 18:1081-1091
55. Ziegler H, Thale R, Lucin P, Muranyi W, Flohr T, Hengel H, Farrell H, Rawlinson W, Koszinowski UH (1997) A mouse cytomegalovirus glycoprotein retains MHC class I complexes in the ERGIC/cis-Golgi compartments. Immunity 6:57-66
56. Wagner M, Gutermann A, Podlech J, Reddehase MJ, Koszinowski UH (2002) Major histocompatibility complex class I allele-specific cooperative and competitive interactions between immune evasion proteins of cytomegalovirus. J Exp Med 196:805-816
57. Holtappels R, Gillert-Marien D, Thomas D, Podlech J, Deegen P, Herter S, Oehrlein-Karpi SA, Strand D, Wagner M, Reddehase MJ (2006) Cytomegalovirus encodes a positive regulator of antigen presentation. J Virol 80:7613-7624
58. Pinto AK, Munks MW, Koszinowski UH, Hill AB (2006) Coordinated function of murine cytomegalovirus genes completely inhibits CTL lysis. J Immunol 177:3225-3234
59. Gold MC, Munks MW, Wagner M, Koszinowski UH, Hill AB, Fling SP (2002) The murine cytomegalovirus immunomodulatory gene m152 prevents recognition of infected cells by M45-specific CTL but does not alter the immunodominance of the M45-specific CD8 T cell response in vivo. J Immunol 169:359-365
60. Munks MW, Gold MC, Zajac AL, Doom CM, Morello CS, Spector DH, Hill AB (2006) Genome-wide analysis reveals a highly diverse CD8 T cell response to murine cytomegalovirus. J Immunol 176:3760-3766
61. Reddehase MJ, Koszinowski UH (1984) Significance of herpesvirus immediate early gene expression in cellular immunity to cytomegalovirus infection. Nature 312:369-371
62. Reddehase MJ, Fibi MR, Keil GM, Koszinowski UH (1986) Late-phase expression of a murine cytomegalovirus immediate-early antigen recognized by cytolytic T lymphocytes. J Virol 60:1125-1129
63. Holtappels R, Grzimek NK, Simon CO, Thomas D, Dreis D, Reddehase MJ (2002) Processing and presentation of murine cytomegalovirus pORFm164-derived peptide in fibroblasts in the face of all viral immunosubversive early gene functions. J Virol 76:6044-6053
64. Pinto AK, Jamieson AM, Raulet DH, Hill AB (2007) The role of NKG2D signaling in inhibition of cytotoxic T-lymphocyte lysis by the Murine cytomegalovirus immunoevasin m152/gp40. J Virol 81:12564-12571
65. LoPiccolo DM, Gold MC, Kavanagh DG, Wagner M, Koszinowski UH, Hill AB (2003) Effective inhibition of K(b)- and D(b)-restricted antigen presentation in primary macrophages by murine cytomegalovirus. J Virol 77:301-308
66. Hengel H, Reusch U, Geginat G, Holtappels R, Ruppert T, Hellebrand E, Koszinowski UH (2000) Macrophages escape inhibition of major histocompatibility complex class I-dependent antigen presentation by cytomegalovirus. J Virol 74:7861-7868
67. Kavanagh DG, Gold MC, Wagner M, Koszinowski UH, Hill AB (2001) The multiple immune-evasion genes of murine cytomegalovirus are not redundant: m4 and m152 inhibit antigen presentation in a complementary and cooperative fashion. J Exp Med 194:967-978
68. del Val M, Hengel H, Hacker H, Hartlaub U, Ruppert T, Lucin P, Koszinowski UH (1992) Cytomegalovirus prevents antigen presentation by blocking the transport of peptide-loaded major histocompatibility complex class I molecules into the medial-Golgi compartment. J Exp Med 176:729-738
69. Smith LM, Shellam GR, Redwood AJ (2006) Genes of murine cytomegalovirus exist as a number of distinct genotypes. Virology 352:450-465
70. Munks MW, Cho KS, Pinto AK, Sierro S, Klenerman P, Hill AB (2006) Four distinct patterns of memory CD8 T cell responses to chronic murine cytomegalovirus infection. J Immunol 177:450-458
71. Holtappels R, Pahl-Seibert MF, Thomas D, Reddehase MJ (2000) Enrichment of immediate-early 1 (m123/pp89) peptide-specific CD8 T cells in a pulmonary CD62L(lo) memory-effector cell pool during latent murine cytomegalovirus infection of the lungs. J Virol 74:11495-11503
72. Karrer U, Sierro S, Wagner M, Oxenius A, Hengel H, Koszinowski U, Phillips RE, Klenerman P (2003) Memory inflation: continuous accumulation of antiviral CD8+ T cells over time. J Immunol 171:3895
73. Karrer U, Sierro S, Wagner M, Oxenius A, Hengel H, Koszinowski UH, Phillips RE, Klenerman P (2003) Memory inflation: continuous accumulation of antiviral CD8+ T cells over time. J Immunol 170:2022-2029
74. Munks MW, Pinto AK, Doom CM, Hill AB (2007) Viral interference with antigen presentation does not alter acute or chronic CD8 T cell immunodominance in murine cytomegalovirus infection. J Immunol 178:7235-7241
75. Reddehase MJ, Simon CO, Podlech J, Holtappels R (2004) Stalemating a clever opportunist: lessons from murine cytomegalovirus. Hum Immunol 65:446-455
76. Lu X, Pinto AK, Kelly AM, Cho KS, Hill AB (2006) Murine cytomegalovirus interference with antigen presentation contributes to the inability of CD8 T cells to control virus in the salivary gland. J Virol 80:4200-4202
77. Simon CO, Holtappels R, Tervo HM, Bohm V, Daubner T, Oehrlein-Karpi SA, Kuhnapfel B, Renzaho A, Strand D, Podlech J et al (2006) CD8 T cells control cytomegalovirus latency by epitope-specific sensing of transcriptional reactivation. J Virol 80:10436-10456
78. Cicin-Sain L, Podlech J, Messerle M, Reddehase MJ, Koszinowski UH (2005) Frequent coinfection of cells explains functional in vivo complementation between cytomegalovirus variants in the multiply infected host. J Virol 79:9492-9502
79. Hedrick SM (2004) The acquired immune system: a vantage from beneath. Immunity 21:607-615